Using AI to improve dermatology referrals
Pilot Study for the Clinical Validation of an Artificial Intelligence Algorithm to Optimize the Appropriateness of Dermatology Referrals.
This study is testing whether an AI tool can help doctors make better referrals to dermatologists for patients with skin conditions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | AI Labs Group S.L Industry-sponsored |
| Locations | 1 site (Barakaldo, Biscay) |
| Trial ID | NCT06228014 on ClinicalTrials.gov |
What this trial studies
This observational study aims to validate an AI algorithm designed to enhance the accuracy of dermatology referrals from primary care physicians. By analyzing the effectiveness of this tool, the study seeks to reduce costs in secondary care, decrease dermatology waiting lists, and optimize clinical workflows within the healthcare system. Patients with skin conditions will be informed about the study and asked to provide consent before data collection begins. The study addresses the common discrepancies in diagnosis between primary care physicians and dermatologists, aiming to improve patient outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with skin pathologies who are willing to participate.
Not a fit: Patients who do not have skin conditions or those unable to comply with study procedures may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more accurate dermatology referrals, improving patient access to specialized care.
How similar studies have performed: Other studies have shown promise in using AI for diagnostic purposes in healthcare, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with skin pathologies. * Patients aged 18 years or older. * Patients who have signed the informed consent for the study. Exclusion Criteria: * Patient who at the investigator\'s discretion will not comply with the study procedures.
Where this trial is running
Barakaldo, Biscay
- University Hospital of Cruces — Barakaldo, Biscay, Spain (Recruiting)
Study contacts
- Study coordinator: Alfonso Medela, MsC
- Email: alfonso@legit.health
- Phone: +34 638127476
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.